-
Mashup Score: 0QuadShot News - 2 year(s) ago
With increasing information overload and packed work schedules, staying up-to-date on the newest oncologic advances is harder than ever. But take heart! The QuadShot is freshly brewed in your inbox four mornings each week so you can quickly down and digest the day’s most pertinent cancer news.
Source: www.quadshotnews.comCategories: Latest Headlines, Oncologists1Tweet
-
Mashup Score: 3Passion of the radiobiologist. - 2 year(s) ago
Remember the pathologic complete response rate with neoadjuvant SBRT for early-stage non-small cell lung cancer (NSCLC) on the MISSILE-NSCLC…
Source: www.quadshotnews.comCategories: Hem/Oncs, Latest HeadlinesTweet-
What has two thumbs and was on the QuadShot three years ago today This guy https://t.co/Kyo7t87EnG
-
-
Mashup Score: 3QuadShot News - 2 year(s) ago
With increasing information overload and packed work schedules, staying up-to-date on the newest oncologic advances is harder than ever. But take heart! The QuadShot is freshly brewed in your inbox four mornings each week so you can quickly down and digest the day’s most pertinent cancer news.
Source: www.quadshotnews.comCategories: Hem/Oncs, Latest HeadlinesTweet-
Thanks for highlighting our work, @QuadShotNews "QuadShot is like the Oscars of oncology." 😅 @EricLehrer @LeilaTchelebi @jryckman3 https://t.co/n23ttvq8lj https://t.co/zh8iXsHtHp
-
-
Mashup Score: 2Personal touch. - 3 year(s) ago
Top Line : What is the optimal prescription dose for lung cancer? The Study : Has any other radiation trial led to more hand-wringing than…
Source: www.quadshotnews.comCategories: Hem/Oncs, Latest HeadlinesTweet-
“Modest dose escalation applied to a uniform population of NSCLC patients is unlikely to show benefit because the majority of patients likely receive a non-optimal radiation dose” - @QuadShotNews @CancerConnector @jtorresroca https://t.co/mIYlSvUAeF
-
-
Mashup Score: 0Will recognise but not apologise. - 3 year(s) ago
Top Line : There’s been an interesting cross-Atlantic divide on the best positron emission tomography (PET) imaging modality for localizing …
Source: www.quadshotnews.comCategories: Hem/Oncs, Latest HeadlinesTweet-
Here's a post from @QuadShotNews that supports the aphorism at UCLA and the VA Greater Los Angeles that "Axumin is good, PSMA is better". #pcsm @abhiAsolanki @DrMHofman https://t.co/nlhbWoy5mG
-
-
Mashup Score: 0Five’s a dime. - 4 year(s) ago
Top Line : Many of us have been treating breast cancers with 5-fraction adjuvant radiation for weeks . The Study : And now we have a pub…
Source: www.quadshotnews.comCategories: Hem/Oncs, Latest HeadlinesTweet-
They even provide summaries to learn more about indications for: Whole Breast Cancer https://t.co/YEOvjeltF6 Partial Breast Cancer https://t.co/L12kW3qnwr Upper-Mid Rectal Cancer https://t.co/jy8snatBFE Low-Interm Risk Prostate Cancer https://t.co/jb0VzOB8Nv
-
-
Mashup Score: 0QuadShot News - 4 year(s) ago
With increasing information overload and packed work schedules, staying up-to-date on the newest oncologic advances is harder than ever. But take heart! The QuadShot is freshly brewed in your inbox four mornings each week so you can quickly down and digest the day’s most pertinent cancer news.
Source: www.quadshotnews.comCategories: Hem/OncsTweet-
Twitter is nice, but @the_quadshow is a much more efficient way to keep up with cancer research publications and presentations. Especially for busy #radoncs. For example, here's an entire year in review that was just sent this past week. SUBSCRIBE here: https://t.co/Ths6HfaL97 https://t.co/c1A3FTkSlz
-
🙏🙏🙏 to @QuadShotNews for highlighting our #anatomist study👇 #Netflix and contour 🤣… ✍️Subscribe here for your daily dose of witty #radonc banter: https://t.co/dTt3V42ENz https://t.co/faQRjhgXSN https://t.co/d7tPUJvhmL